Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to pulmonary and …

COVID‐19 is caused by a novel SARS‐CoV‐2 leading to pulmonary and extra‐pulmonary
manifestations due to oxidative stress (OS) development and hyperinflammation. COVID‐19 …

The gut microbiome plays a pivotal role in the modulation of host responses during viral
infections, and recent studies have underscored its significance in the context of coronavirus …

The epithelial‐to‐mesenchymal transition (EMT) plays a central role in the development of
cancer metastasis and resistance to chemotherapy. However, its pharmacological treatment …

The anti-inflammatory and neuroprotective effects of short chain fatty acid (SCFA) butyrate
have been explored in a wide array of neurological pathologies. It is a 4-carbon SCFA …

The gut microbiome is known to play an important role in the day-to-day physiology and
health of the human host. It is, therefore, not surprising that there is interest surrounding the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus
Disease 19 (COVID-19), a disease that has affected more than 500 million people …

Abstract Coronavirus disease (COVID-19) is an acute respiratory disease caused by the
new coronavirus (SARS-CoV-2) that has spread throughout the world causing millions of …

Post-COVID syndrome (PCS) patients have reported a wide range of symptoms, including
fatigue, shortness of breath, and diarrhea. Particularly, the presence of gastrointestinal …

Microbial metabolites have emerged as key players in the interplay between diet, the gut
microbiome, and host health. Two major classes, short-chain fatty acids (SCFAs) and …